Dose rounding bevacizumab and its biosimilars to reduce drug waste in the oncology care model in a community oncology network

被引：0
|
作者：
Indurlal, Puneeth
Alam, Naiyar
Garey, Jody S.
Wilfong, Lalan S.
机构：
[1] McKesson, US Oncol Network, The Woodlands, TX USA
[2] US Oncol Network, Texas Oncol, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1529
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The financial impact of reducing drug waste with biosimilar transition of trastuzumab in the Oncology Care Model for the US Oncology Network.
    Fernandez, Jennifer
    Indurlal, Puneeth
    Garey, Jody S.
    Dave, Neal
    Cleveland, Richard
    Agena, Jody
    Malhotra, Rajat
    Wilfong, Lalan S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 11 - 11
  • [2] Comparative cost savings of biosimilar and dose rounding utilization in oncology care
    Abdelmeseh, Verona
    Brown, Britny R.
    Huynh, Justin P.
    Zullo, Andrew R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (06) : 1437 - 1442
  • [3] The Dual Rounding Model: Forging Therapeutic Alliances in Oncology and Palliative Care
    Baxley, Carey E.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2016, 20 (02) : 215 - 216
  • [4] Community oncology care delivery staffing model
    Fryefield, David C.
    Kafora, Roberta
    Bradshaw-Hucko, Lori
    Tribble, Chris
    Jensen, Terry
    Chentnik, Tom
    Beveridge, Roy
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [5] Utilization of Clinical Pathways Can Reduce Drug Spend Within the Oncology Care Model
    Hertler, Andrew
    Chau, Sang
    Khetarpal, Rani
    Bassin, Ed
    Dang, Jeff
    Koppel, Daniel
    Damarla, Vijay
    Wade, James
    JCO ONCOLOGY PRACTICE, 2020, 16 (05) : 251 - +
  • [6] A community oncology practice financial experience in oncology care model pilot (OCM).
    Akhtar, Adil Jamal
    Margolis, Jeffrey H.
    Sheth, Karna
    Maxwell, Karma
    Muskovitz, Andrew A.
    Zekman, Richard Philip
    Howard, George
    Ballouz, Samer
    Qamruzzaman, Yusuf
    Balaraman, Savitha
    Ibrahim, Mohammed
    Fabbiano, Maria
    Folbe, Mitchell
    Ogaily, Mohammed S.
    Stortz, Lexi
    Pancholi, Shehnaz
    Tauquir, Anoosha Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Financial impact of biosimilar adoption in the oncology care model for the US Oncology Network.
    Wilfong, Lalan S.
    Indurlal, Puneeth
    Dominguez, Kaci
    Garey, Jody S.
    Howell, Josh
    Staggs, Stuart
    Neubauer, Marcus A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18749 - E18749
  • [8] An assessment of the provider financial risk impacts of adoption of biosimilars in the Medicare Oncology Care Model
    Roth, Joshua A.
    Chaudhry, Basit Iqbal
    Yue, Andrew
    Kelton, John M.
    Shelbaya, Ahmed
    Tran, Lisa
    Li, Meng
    Yang, Jingyan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Provider Perceptions of a Novel Inpatient Co-Rounding Model Integrating Medical Oncology, Neuro-Oncology, and Radiation Oncology for the Care of Patients with Advanced Cancer
    Ni, L.
    Viner, J.
    Phuong, C.
    Liu, S. J.
    Yee, E.
    Petrofsky, M.
    Kwon, D. H.
    Daras, M.
    Brondfield, S.
    Boreta, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S61 - S61
  • [10] Financial impact of fixed-dose versus weight-based dosing approaches for pembrolizumab and nivolumab in the Oncology Care Model for The US Oncology Network (The Network)
    Fernandez, Jennifer
    Indurlal, Puneeth
    Garey, Jody S.
    Wilfong, Lalan S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345